HKU Surgery

HKU Surgery Official page of the Department of Surgery, HKU
Our website: https://www.surgery.hku.hk

【🎉TTS-ILTS Mentor-Mentee Award】Prof. Nancy Man and Dr. Liu Jiang have been honored with the TTS-ILTS Mentor-Mentee Award...
30/09/2026

【🎉TTS-ILTS Mentor-Mentee Award】

Prof. Nancy Man and Dr. Liu Jiang have been honored with the TTS-ILTS Mentor-Mentee Award at the 31st International Congress of The Transplantation Society (TTS 2026) held in Sydney from 20-23 Sep 2026. Congratulations to both Prof. Nancy Man and Dr. Liu Jiang for their well-deserved recognition and continued contributions to the field!

【The Division of Urology Introduces Single-Incision Robot-Assisted Radical Prostatectomy泌尿外科引入單切口機械臂輔助根治性前列腺切除術】Since in...
29/09/2026

【The Division of Urology Introduces Single-Incision Robot-Assisted Radical Prostatectomy
泌尿外科引入單切口機械臂輔助根治性前列腺切除術】

Since introducing single-incision robot-assisted radical prostatectomy last December, the urology team at the Department of Surgery, The University of Hong Kong (HKU), and Queen Mary Hospital has performed 10 procedures.
Prostate cancer is the third most common cancer among men in Hong Kong. Dr Ng Tsui Lin Ada, Head of Urology and Honorary Clinical Associate Professor in HKU’s Department of Surgery, noted that radical prostatectomy is one treatment option. The team remains committed to treating the disease effectively while reducing surgical trauma and supporting patients’ recovery.
Dr Tsang Chiu Fung, Consultant in Urology and Honorary Clinical Associate Professor in HKU’s Department of Surgery, explained that conventional robot-assisted surgery generally requires several abdominal incisions. The new technique uses a single incision of approximately 4–5 cm in the lower abdomen, through which multiple robotic arms are introduced to perform the resection, control bleeding and place sutures.
Dr Wong Hoi Lung, Associate Consultant in Urology and Honorary Clinical Assistant Professor in HKU’s Department of Surgery, said that, according to the team’s data so far, both operative time and average length of hospital stay have decreased markedly. The team hopes to continue building its clinical experience and collecting data, explore the technique’s use in other procedures, and share its experience with more hospitals so that suitable patients can benefit.
We extend our heartfelt thanks to the multidisciplinary clinical team, surgical team, anaesthesia team and nursing team for their dedication and collaboration. We are also grateful to the patients who have shared their treatment experiences. Let us continue working together to advance minimally invasive urological surgery and clinical services in Hong Kong, and offer patients better treatment options.

香港大學外科暨瑪麗醫院泌尿外科團隊自去年12月引入單切口機械臂輔助根治性前列腺切除術以來,已完成10宗手術。
前列腺癌是本港男性第三大常見癌症。泌尿外科主管兼港大外科名譽臨床副教授吳翠蓮醫生指出,根治性前列腺切除術是其中一種治療方案,而如何在有效治療疾病的同時減少手術創傷、幫助病人復元,是團隊持續努力的方向。
泌尿外科顧問醫生兼港大外科名譽臨床副教授曾昭鋒醫生表示,傳統機械臂手術一般需要在腹部開設多個切口,而新技術則透過下腹一個約4至5厘米的切口,讓多支機械臂進入體內,完成切除、止血及縫合。
泌尿外科副顧問醫生兼港大外科名譽臨床助理教授黃海龍醫生指出,根據團隊目前的數據,手術時間和病人平均住院日數明顯減少。團隊期望繼續累積臨床經驗及數據,探索技術在其他手術的應用,並與更多醫院分享經驗,讓合適的病人受惠。
衷心感謝跨專業臨床團隊、外科團隊、麻醉科團隊及護理團隊的專業付出與協作,亦感謝病人願意分享治療經歷。讓我們繼續攜手推動香港泌尿外科微創手術及臨床服務發展,為病人提供更優質的治療選擇。


#港大外科 #瑪麗醫院 #泌尿外科 #前列腺癌 #單切口機械臂手術

【🎉First Prize in CIET 2026 Poster Award】Congratulations to Dr. Vanessa Cheung on receiving 1st Prize in the Poster Award...
24/09/2026

【🎉First Prize in CIET 2026 Poster Award】

Congratulations to Dr. Vanessa Cheung on receiving 1st Prize in the Poster Award at the Critical Issues in Endovascular Therapy Symposium (CIET 2026), held in Singapore on 4-6 September 2026. This international symposium brought together clinicians and researchers to discuss advances in peripheral endovascular therapy, providing an important platform for the exchange of innovations and disease management.

Dr. Cheung’s award-winning presentation, “Expedited Management Protocol for Chronic Limb-Threatening Ischaemia with Tissue Loss,” highlighted a pragmatic approach to improving timely care for patients at high risk of limb loss. The study was conducted at PYNEH under the supervision of Dr. Skyi Pang. This recognition reflects the team’s commitment to clinically meaningful research and improving outcomes for patients with chronic limb-threatening ischaemia.

Congratulations again to Dr. Cheung and the team on this excellent international achievement.

【HKUSurgery Team Wins Awards at BIOHK2026】 Congratulations to Professor John Leung and his multidisciplinary team on the...
16/09/2026

【HKUSurgery Team Wins Awards at BIOHK2026】

Congratulations to Professor John Leung and his multidisciplinary team on their outstanding success at BIOHK2026.

As one of the Top 10 Projects of HKUMedXelerate 2026, Professor Leung’s team presented their project, “Histology at the Operating Table: Rapid Reversible Clearing and Volumetric Imaging of Intact Specimens” during the BIOHK2026 Live Pitch Competition. On Asia’s premier biotechnology stage, the team had the opportunity to showcase their technology to global investors and industry leaders in order to secure partnerships for future development.

Their exceptional presentation earned them three accolades:
• BIOHK Innovation Spotlight Award (BIOHK 醫療創新焦點獎)
• BIOHK Global Market Potential Award (BIOHK 國際市場潛力獎)
• BIOHK Investor’s Choice Award (BIOHK 投資人之選大獎)

With support from industry partner Dr. Hei Ming Lai, and a multidisciplinary clinical team including Professor Gilberto Leung, pathologists Professor Joshua Li and Dr. Elson Ho, this award-winning project aims to make intraoperative diagnosis fast and accurate, using novel technology that images whole specimens at speed without destruction or irreversible processing.

As part of the HKUMedXelerate 2026 Road Show, Professor John Leung's team will continue their journey at BIOCHINA2026 in October, followed by other flagship events at Wuxi and Hangzhou. We wish them continued success as they take this groundbreaking project to new heights.

【ENT Profession shines through BIOHK2026】BIOHK2026, the Hong Kong International Biotechnology Conference and Exhibition,...
15/09/2026

【ENT Profession shines through BIOHK2026】

BIOHK2026, the Hong Kong International Biotechnology Conference and Exhibition, concluded successfully last week, bringing together leading researchers, clinicians, and industry professionals to explore the latest advances in biotechnology and healthcare innovation.

We are proud to share that Professor Stephanie Wong from the Division of Otorhinolaryngology was invited to speak at the conference. In her presentation, “Redefining Salvage Treatment in Locally Recurrent Nasopharyngeal Carcinoma: Neoadjuvant Immune-Chemotherapy as a Gateway to Surgical Cure”, she highlighted emerging evidence and clinical research that are reshaping treatment strategies for patients with locally recurrent nasopharyngeal carcinoma.

She also participated in the panel discussion, “One Protocol, Many Sites - Cracking the Code of Cross-Border Multicenter Trials”, where she exchanged insights with international experts on the challenges and opportunities of conducting multicentre clinical trials across different healthcare systems and regions.

Through research, collaboration, and innovation, we remain committed to advancing evidence-based practice and delivering the highest standard of care for our patients.

【The 12th Masterclass in Urological Robotic and Laparoscopic Surgery】The Department of Surgery, HKUMed, successfully hos...
14/09/2026

【The 12th Masterclass in Urological Robotic and Laparoscopic Surgery】

The Department of Surgery, HKUMed, successfully hosted the 12th Masterclass in Urological Robotic and Laparoscopic Surgery on 12 September 2026. This annual event continues to serve as a premier platform for innovation, collaboration, and advanced surgical education.

We were honoured to welcome Professor Theodoros Tokas from the University General Hospital of Heraklion, University of Crete, and Professor Li Xuesong from Peking University First Hospital, who shared their expertise and demonstrated the latest advancements in urological robotic and laparoscopic surgery.

This year, we expanded the hands-on training programme in two significant ways. First, participants gained direct experience with two distinct robotic surgical platforms, providing valuable exposure to cutting-edge robotic technologies. Second, we incorporated cadaveric models into the curriculum, offering realistic demonstrations of complex surgical anatomy and enhancing the learning experience.

We would like to extend our sincere gratitude to our distinguished faculty members, industry partners, and participants for their invaluable contributions in making this event a success.

【🌎Division of Urology at the 2nd Academic Annual Meeting of the Male Health Professional Committee of the Guangdong Clin...
03/09/2026

【🌎Division of Urology at the 2nd Academic Annual Meeting of the Male Health Professional Committee of the Guangdong Clinical Medical Association 2026✨】

The Division of Urology participated in the 2nd Academic Annual Meeting of the Male Health Professional Committee of the Guangdong Clinical Medical Association and the 22nd Session of the Masterclass on Microsurgical and Minimally Invasive Andrology, held in Guangzhou from August 23 to 29, 2026.

Dr. Hung Pui Long Wilson chaired a session on "Surgical Treatment for Infertility" in the meeting and delivered a lecture on "Adolescent Klinefelter Fertility Preservation" during the masterclass. Dr. Ho Garm Chi, Justin received a certificate of training for microsurgical and minimally invasive andrological surgeries.

The meeting brought together hundreds of leading experts in andrology from across the country and beyond. It aimed to share the latest research findings, exchange innovative ideas, and foster potential collaborations in andrological surgeries in China. Congratulations to the team for this recognition and for representing our department on the stage of Mainland China in the field of andrology for the first time.

【🔬 Empowering Choice: Advancing Personalized Breast Cancer Care】✨ As precision medicine continues to reshape cancer trea...
02/09/2026

【🔬 Empowering Choice: Advancing Personalized Breast Cancer Care】

✨ As precision medicine continues to reshape cancer treatment, one question remains at the heart of modern oncology: how can care be tailored not only to the disease, but to the individual?

At the Hospital Authority Convention 2026, Professor Ava Kwong shared insights that continue to influence the evolution of personalised breast cancer care. In her presentation, “Empowering Choice: BRCA, Genomic Testing and Personalized Therapy in Breast Cancer Care,” she highlighted the shift from a traditional "one-size-fits-all" approach towards a genomics-driven model of care.

Through genomic profiling, multigene assays, and germline testing, clinicians are now able to tailor treatment strategies to each individual, enabling more targeted therapies, safer treatment de-escalation for low-risk patients, and more informed decisions on long-term risk and prevention.

These advancements are built on nearly two decades of work by the Division of Breast Surgery. In 2007, the team led the establishment of a HKU’s research clinic, which was later transformed into the Hong Kong’s first high-risk genetics clinic for hereditary breast and ovarian cancer syndrome, supported by the Hospital Authority. This pioneering effort has strengthened clinical data and research capacity, helping to drive the development of genomic-based breast cancer care.

🎓 Looking ahead, this work continues to shape the future through education. The specialised Genetic Counselling track under the Master of Medical Sciences programme at HKUMed is training the next generation of professionals in medical genomics and psychosocial care. As Admission Advisor, Professor Kwong emphasises that advancing both research and talent development will be key to delivering truly personalised, patient-centred care.

🔗 Learn more: https://www.mmedsc.hku.hk/programme/tracks_and_specialisations/genetic-counselling

【🌏 Asian Pacific Foregut Society Inaugural Congress】We are delighted to announce that the Inaugural Congress of the Asia...
01/09/2026

【🌏 Asian Pacific Foregut Society Inaugural Congress】

We are delighted to announce that the Inaugural Congress of the Asian Pacific Foregut Society (APFS) will be held in Hong Kong on 24–25 October 2026.

Bringing together over 20 renowned international and regional experts, the Congress will focus on the latest developments in Gastroesophageal Reflux Disease (GERD), Upper GI Motility Disorders, and Foregut Innovations.
In addition, Pre-Congress Workshops will feature hands-on learning and expert demonstrations in Laparoscopic & Robotic Fundoplication, Esophageal Functional Testing, Foregut Endoscopy.

The Asian Pacific Foregut Society (APFS) is a newly established regional organization working in partnership with the American Foregut Society (AFS) and the European Foregut Society (EFS). Built upon a unique model of joint leadership by gastroenterologists and surgeons, the Society currently includes representatives from Chinese Mainland, Hong Kong, Japan, Korea, and Singapore, and will further expand its regional footprint to Australia, Malaysia, and the Philippines at this inaugural meeting.

🤝 APFS is dedicated to advancing the field of benign foregut diseases, an area that remains under-recognized across the Asia-Pacific region. Through close collaboration between surgeons and gastroenterologists, APFS aims to establish a vibrant academic platform that enhances professional education, raises public awareness, and promotes regional research and collaboration.

📢 Submit your abstracts now and join us!
🗓️ Call for Abstracts Deadline: 15 September 2026 (Tuesday)
🗓️ Registration Deadline: 9 October 2026 (Friday)
🌐 Register now: https://apfs2026hk.org/

We look forward to welcoming you to Hong Kong this October! 🎉

【🎉 2026 TUA Annual Meeting – Scientific Programs】The 2026 Taiwan Urological Association (TUA) Annual Meeting Scientific ...
24/08/2026

【🎉 2026 TUA Annual Meeting – Scientific Programs】

The 2026 Taiwan Urological Association (TUA) Annual Meeting Scientific Programs was successfully held in Taipei on 22–23 August 2026.

We are proud to announce that Dr. Wong Hoi Lung Simon from the Division of Urology of the Department Of Surgery, HKUMed and Queen Mary Hospital, presented:

🔹 “Single Port Robot-Assisted Radical Prostatectomy Using the da Vinci Xi System: Early Experience from Hong Kong”

This presentation highlights our department’s pioneering work in single-port robotic surgery, a minimally invasive approach offering patients smaller incisions, reduced pain, and faster recovery.

Congratulations to Dr. Wong and the team for this outstanding achievement and for representing Hong Kong on the international stage!

Address

Queen Mary Hospital
Hong Kong

Alerts

Be the first to know and let us send you an email when HKU Surgery posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The School

Send a message to HKU Surgery:

Shortcuts

Share